Med Pride — Class II drug recall D-0642-2026
Ongoing recall by Dabur India Limited, reported 2026-06-24, distributed nationwide. CGMP Deviations; deficiencies observed during FDA inspection
| Recall number | D-0642-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Dabur India Limited, Dadra And Nagar Haveli, India |
| Recall initiated | 2026-06-02 |
| Classified | 2026-06-26 |
| Reported by FDA | 2026-06-24 |
| Distributed | Nationwide (US) |
| Quantity | 8,996 tubes |
| Reason classes | cgmp |
| UPC / GTIN / UDI-DI | 00352410302558 |
| Lot numbers | 001, 002, 003, 004, 005, 006, 007, 008, 009, 010, 012, 013, 023, 024, 025, 027, 028, 029, 031, 032, 033, 034, 035 |
Product
Med Pride, Triple Antibiotic Ointment, Bacitracin Zinc 400 units, Neomycin Sulfate 5 mg, Polymyxin B 5000 units, 1oz (28.3g) tubes, Manufactured for: Shield Line LLC, 59 Hook Road, Bayonne, NJ 07002 USA, Made in India, UPC 3 52410 30255 8.
Reason for recall
CGMP Deviations; deficiencies observed during FDA inspection
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0642-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.